Denali Therapeutics Information
Contact top employees from
Denali Therapeutics
Summary
Denali Therapeutics is a public company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Ryan Watts. Its headquarters is located at South San Francisco, California, USA. The number of employees ranges from 250 to 500. The annual revenue of Denali Therapeutics varies between 100M and 500M. Total funding of the company - $597M. To connect with Denali Therapeutics employee register on SignalHire.
Organization Website | denalitherapeutics.com |
Social Links |  |
Phone Number | 650-866-8548 |
Industries | |
Headquarters Location | 161 Oyster Point Blvd, South San Francisco, California, 94080 US |
Employees Size | 500-1000 employees |
Specialties | Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals |
SIC Code | 2834, 2836 |
DMA Code | San Francisco Bay Area |
Founded | 2015 |
Estimated Annual Revenue | $100M - 500M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2019 | Privately Held | 25 - 100 | 19M | $113.4M | |
| 2017 | Privately Held | 1 - 25 | < 1M | $26M | |
| 2013 | Public Company | 100 - 250 | 24.6M | $407.5M | |
| 2012 | Public Company | 25 - 100 | < 1M | $308.1M |
Estimated Website Traffic
The chart shows a growth in traffic to the denalitherapeutics.com website. In November, traffic increased to 32698, compared to 32675 in the previous month. The highest traffic in 2025 was recorded in August, reaching 33537 visits.
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Denali Therapeutics shows a diverse range of experience levels:
7% have been with the company for less than 1 year18% for 1–2 years28% for 3–4 years17% for 5–7 years22% for 8–10 years8% have over 11 years of service at Denali TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Denali Therapeutics
Rachel Redfern
Senior Project Administrative Coordinator
Yashas Rajendra
Director & Principal Scientist
Jenna Schorer
Senior Contracts Manager and Records Manager
JAMAL ALKABSH
Scientist
Elaine Tran
Senior Manager QC for QA
Emelia Blankenship
Bioprocess Technician
Vignesh Kashni
Network Security Engineer
Hayley LaRiviere
MSAT Engineer - Consultant
Joseph Bai
Director of Technology
Anshu Bhattacharya
Postdoctoral Scientist
Catherine Heffner
Postdoctoral Scientist
Matt McCabe
Director, R&D Finance
Lihong Zhan
Principal Scientist
Crystal Dodd
Associate Director Patient Access and Experience
David Penshorn
Senior Nonclinical Operations Manager
Darren Hassey
Executive Director, Quality
Ya Ting Chang
Scientist
Derek Jensen
Senior Operations Manager
Jennifer Chiu
Regulatory Therapeutic Area Lead
Tufan Gokirmak
Associate Director, Oligonucleotide
Stanislav Kocheryhin
Director, Commercial Finance and Accounting
Heller Chen
Director, Clinical Pharmacology
Keenan Morris
Senior Quality Assurance Specialist
Angela Liu
Associate Director - Commercial Finance
Ellen Chien
Principal Scientist
Similar Companies
FAQ
Denali Therapeutics operates in the Biotech industries. More details can be found on the official website: denalitherapeutics.com.
The headquarters of Denali Therapeutics are located in South San Francisco, United States.
The current CEO of Denali Therapeutics is Ryan Watts
You can contact Denali Therapeutics by phone at 650-866-8548.
Denali Therapeutics currently employs 500-1000 people.
Denali Therapeutics's revenue is approximately 357.1M.
Well-known competitors of Denali Therapeutics include Veracyte Inc. | C2i Genomics, LevitasBio, Alector and Quince Therapeutics.
